title: [Intraumbilical therapy of fetal supraventricular tachycardia].
abstract: The supraventricular tachycardia represents the life threatening disease, which may cause severe heart failure or even during foetal life. The authors present case report of the foetus aged 23 weeks of gestation in whom the supraventricular tachycardia was resistant to standard transplacental treatment by using digoxin and sotalol. The successful rhythm conversion was achieved by intracordal infusion of amiodarone. Further uncomplicated course of pregnancy reached term and healthy boy was subsequently born without having additional psychomotoric complications.
authors.affiliation: Dĕtské kardiocentrum FN Motol, Praha.
authors.forename: V
authors.initials: V
authors.lastname: Tomek
authors.forename: J
authors.initials: J
authors.lastname: Marek
authors.forename: I
authors.initials: I
authors.lastname: Spálová
authors.forename: R
authors.initials: R
authors.lastname: Vlk
authors.forename: J
authors.initials: J
authors.lastname: Janousek
authors.forename: M
authors.initials: M
authors.lastname: Bresták
authors.forename: E
authors.initials: E
authors.lastname: Kulovaný
authors.forename: J
authors.initials: J
authors.lastname: Skovránek
mesh_terms: D000328:Adult; D000638:Amiodarone / Q000008:administration & dosage*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D014471:Umbilical Veins
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone